UPDATE: Brean Capital Cuts Osiris Therapeutics (OSIR) to Sell on Evidence of 'Aggressive Accounting'
Tweet Send to a Friend
(Updated - November 17, 2015 9:55 AM EST)
Brean Capital downgraded Osiris Therapeutics (NASDAQ: OSIR) from Hold to Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brean Capital downgraded Osiris Therapeutics (NASDAQ: OSIR) from Hold to Sell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
